Identifying glioblastoma gene networks based on hypergeometric test analysis.
Patient specific therapy is emerging as an important possibility for many cancer patients. However, to identify such therapies it is essential to determine the genomic and transcriptional alterations present in one tumor relative to control samples. This presents a challenge since use of a single sa...
Main Authors: | Vasileios Stathias, Chiara Pastori, Tess Z Griffin, Ricardo Komotar, Jennifer Clarke, Ming Zhang, Nagi G Ayad |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4281219?pdf=render |
Similar Items
-
Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
by: Sze Kiat Tan, et al.
Published: (2018-03-01) -
Drug and disease signature integration identifies synergistic combinations in glioblastoma
by: Vasileios Stathias, et al.
Published: (2018-12-01) -
Basic Hypergeometric Functions as Limits of Elliptic Hypergeometric Functions
by: Fokko J. van de Bult, et al.
Published: (2009-06-01) -
Hypergeometric series representations of Feynman integrals by GKZ hypergeometric systems
by: René Pascal Klausen
Published: (2020-04-01) -
Organoid Models of Glioblastoma and Their Role in Drug Discovery
by: Matthew J. Rybin, et al.
Published: (2021-02-01)